KESIMPTA sol inj 20 mg/0.4ml stylo pré 0.4 ml
7680677580017
CH-67758
L04AG12
01.99.0.
Reimbursement limitations:
KESIMPTA
Pour le traitement des patients adultes atteints de formes récurrentes actives de la sclérose en …
1 / 3
google
Details
- Product number
- 6775801
- CPT
- -
- Packaging group
- 1
- Unit
- Stück
- Composition
- ofatumumabum 20 mg, argininum, natrii acetas trihydricus, natrii chloridum, polysorbatum 80, dinatrii edetas, acidum hydrochloridum 25 per centum, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml corresp. natrium 0.92 mg.
Articles (1)
Kesimpta, Injektionslösung in Fertigpen
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.92 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1255.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2021
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 67758
- Drug name
- Kesimpta, Injektionslösung in Fertigpen
- Galenic form
- INLFP
- ATC Code
- L04AG12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 01/02/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- KESIMPTA sol inj 20 mg/0.4ml stylo pré 0.4 ml
- Description (DE)
- KESIMPTA Inj Lös 20 mg/0.4ml Fertpen 0.4 ml
- Market launch
- 01/02/2021
- Narcotic (BTM)
- No